Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters. (Record no. 29782085)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01188 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250518043513.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 202004s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 2531-0437 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.pulmoe.2019.04.005 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Estevinho, F |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20200428 |
245 00 - TITLE STATEMENT | |
Title | Treatment of advanced EGFR-mutant NSCLC patients: Sequencing matters. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Pulmonology |
Date of publication, distribution, etc. | |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 306-309 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Letter |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Clinical Trials, Phase III as Topic |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | DNA Mutational Analysis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | ErbB Receptors |
General subdivision | genetics |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Lung Neoplasms |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mutation |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Protein Kinase Inhibitors |
General subdivision | therapeutic use |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Felizardo, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Fernandes, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Figueiredo, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lopes, J A |
773 0# - HOST ITEM ENTRY | |
Title | Pulmonology |
Related parts | vol. 25 |
-- | no. 5 |
-- | p. 306-309 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.pulmoe.2019.04.005">https://doi.org/10.1016/j.pulmoe.2019.04.005</a> |
Public note | Available from publisher's website |
No items available.